United States

Restorix Health Inc (ACOL)

Track

Ticker: ACOL
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Barnett Andrew Gary CEO and CFO Executive Director
Transaction date
Purchase
Price
307.73
Quantity 23,703 +41.7%
Value US$123,637
Barnett Andrew Gary CEO and CFO Executive Director
Transaction date
Purchase
Price
426.55
Quantity 52,779 +8.7%
Value US$1,236,848
Barnett Andrew Gary CEO and CFO Executive Director
Transaction date
Purchase
Price
487.87
Quantity 1,601 +1.9%
Value US$4,806,477
Barnett Andrew Gary CEO and CFO Executive Director
Transaction date
Purchase
Price
0.55
Quantity 9,450 +22.5%
Value US$5,198
Barnett Andrew Gary CEO and CFO Executive Director
Transaction date
Purchase
Price
0.65
Quantity 10,000 +31.2%
Value US$6,500
Barnett Andrew Gary CEO and CFO Executive Director
Transaction date
Purchase
Price
0.65
Quantity 5,000 +18.5%
Value US$3,250
Barnett Andrew Gary CEO and CFO Executive Director
Transaction date
Purchase
Price
0.55
Quantity 9,000 +50.0%
Value US$4,950
Barnett Andrew Gary CEO and CFO Executive Director
Transaction date
Purchase
Price
0.51
Quantity 2,500 +16.1%
Value US$1,275
Barnett Andrew Gary CEO and CFO Executive Director
Transaction date
Purchase
Price
0.45
Quantity 5,000 +47.6%
Value US$2,250
Barnett Andrew Gary CEO and CFO Executive Director
Transaction date
Purchase
Price
0.46
Quantity 10,500 +inf%
Value US$4,875
DeNobile John Non-Executive Director
Transaction date
Sale
Price
1.85
Quantity 45,945 -2.2%
Value US$84,998
DeNobile John Non-Executive Director
Transaction date
Sale
Price
2.00
Quantity 100,000 -4.5%
Value US$200,000
DeNobile John President Executive Director Large shareholder
Transaction date
Purchase
Price
1.34
Quantity 74,627 +3.3%
Value US$100,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2009-07-10 2009-07-09 B Purchase Barnett Andrew Gary

CEO and CFO

Executive Director
23,703 +41.7%
307.73
US$123,637 		23,703 +41.7% 307.73 US$123,637
2009-06-29 2009-06-25 B Purchase Barnett Andrew Gary

CEO and CFO

Executive Director
52,779 +8.7%
426.55
US$1,236,848 		52,779 +8.7% 426.55 US$1,236,848
2009-06-23 2009-06-19 B Purchase Barnett Andrew Gary

CEO and CFO

Executive Director
1,601 +1.9%
487.87
US$4,806,477 		1,601 +1.9% 487.87 US$4,806,477
2009-06-17 2009-06-15 B Purchase Barnett Andrew Gary

CEO and CFO

Executive Director
9,450 +22.5%
0.55
US$5,198 		9,450 +22.5% 0.55 US$5,198
2009-06-10 2009-06-09 B Purchase Barnett Andrew Gary

CEO and CFO

Executive Director
10,000 +31.2%
0.65
US$6,500 		10,000 +31.2% 0.65 US$6,500
2009-06-10 2009-06-08 B Purchase Barnett Andrew Gary

CEO and CFO

Executive Director
5,000 +18.5%
0.65
US$3,250 		5,000 +18.5% 0.65 US$3,250
2009-06-08 2009-06-05 B Purchase Barnett Andrew Gary

CEO and CFO

Executive Director
9,000 +50.0%
0.55
US$4,950 		9,000 +50.0% 0.55 US$4,950
2009-06-08 2009-06-02 B Purchase Barnett Andrew Gary

CEO and CFO

Executive Director
2,500 +16.1%
0.51
US$1,275 		2,500 +16.1% 0.51 US$1,275
2009-06-02 2009-05-29 B Purchase Barnett Andrew Gary

CEO and CFO

Executive Director
5,000 +47.6%
0.45
US$2,250 		5,000 +47.6% 0.45 US$2,250
2009-06-02 2009-05-29 B Purchase Barnett Andrew Gary

CEO and CFO

Executive Director
10,500 +inf%
0.46
US$4,875 		10,500 +inf% 0.46 US$4,875
2008-07-01 2008-06-30 S Sale DeNobile John Non-Executive Director
45,945 -2.2%
1.85
US$84,998 		45,945 -2.2% 1.85 US$84,998
2008-04-18 2008-04-10 S Sale DeNobile John Non-Executive Director
100,000 -4.5%
2.00
US$200,000 		100,000 -4.5% 2.00 US$200,000
2006-04-18 2005-06-06 B Purchase DeNobile John

President

Executive Director Large shareholder
74,627 +3.3%
1.34
US$100,000 		74,627 +3.3% 1.34 US$100,000
Explore more

More insider trading research around Restorix Health Inc

More insider trades in United States
Insider trading in North America